Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The updates are minor adjustments that do not modify core study details such as eligibility, endpoints, or enrollment. The study’s primary purpose remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:16:14.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:12:57.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Update includes a version upgrade to v3.1.0 and removal of v3.0.2, with several added and removed contact details and identifiers.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:04.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:07:38.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-06T14:39:00.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on chemical actions, pharmacologic actions, and therapeutic uses. The previous version's specific location terms and drug information related to Pembrolizumab have been removed.
    Difference
    1%
    Check dated 2025-08-30T11:24:47.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.